Neffy nasal spray shows comparable efficacy to IM epinephrine for type I allergic reactions, with 92.3% symptom resolution after 1 dose.
Vistagen Inc VTGN revealed a new mechanism of action data from a preclinical tissue distribution study in laboratory rats. The study demonstrated that a single intranasal administration of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results